Xylem’s fourth quarter results were driven by disciplined execution and operational improvements across its portfolio, though the market reacted negatively due to concerns about future growth.

Xylem Inc. (NYSE:XYL) Q4 2025 Earnings Call Transcript February 10, 2026 Xylem Inc. misses on earnings expectations. Reported EPS is $1.37 EPS, expectations were $1.42. Operator: Good day, everyone, ...

Segment EBITDA margin increased 60 basis points year over year. Driven by productivity and price, offset by inflation, volume ...

Scott Davis, Melius Research: Asked when the 80/20 simplification would shift from being a headwind to a tailwind. Pine indicated "2026 is kind of an inflection point," focusing on sales force ...

Getting there has involved major changes to the project. Nackerman said after extensive input from neighbors, the developers ...

The essence of structural genomics is to start from the gene sequence, produce the protein and determine its three-dimensional structure. The challenge, once the structure is determined, is to extract ...

Twenty years ago John Maddox published a celebrated News and Views article in Nature 1 in which he provocatively wrote: “One of the continuing scandals in the physical sciences is that it remains ...

Sean Ross is a strategic adviser at 1031x.com, Investopedia contributor, and the founder and manager of Free Lances Ltd. Gordon Scott has been an active investor and technical analyst or 20+ years. He ...